<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><description>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 25 Apr 2021 21:30:40 +0800</pubDate><image><url>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</url><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>盘点2021上市的抗体新药-（3）loncastuximab tesirine-lpyl</title><link>https://mp.weixin.qq.com/s/Oo6fv89AqG6BhX3FETiUyQ</link><description></description><content:encoded><![CDATA[盘点2021上市的抗体新药-（3）loncastuximab tesirine-lpyl]]></content:encoded><pubDate>Sun, 25 Apr 2021 19:32:01 +0800</pubDate></item><item><title>新冠疫苗接种进展和竞争格局</title><link>https://mp.weixin.qq.com/s/use498pvusKZpJJK6pEwmw</link><description></description><content:encoded><![CDATA[新冠疫苗接种进展和竞争格局]]></content:encoded><pubDate>Sun, 25 Apr 2021 19:32:01 +0800</pubDate></item><item><title>盘点2021上市的抗体新药-（2）dostarlimab-gxly</title><link>https://mp.weixin.qq.com/s/iHeO1a8QhHXjgsUgDmw5jQ</link><description></description><content:encoded><![CDATA[盘点2021上市的抗体新药-（2）dostarlimab-gxly]]></content:encoded><pubDate>Sat, 24 Apr 2021 10:25:00 +0800</pubDate></item><item><title>自免明星靶点IL-17：从发现到靶向治疗</title><link>https://mp.weixin.qq.com/s/9l8o7MerYRyj_X5hXgk7XQ</link><description></description><content:encoded><![CDATA[自免明星靶点IL-17：从发现到靶向治疗]]></content:encoded><pubDate>Fri, 23 Apr 2021 19:47:59 +0800</pubDate></item><item><title>博际生物喊你入职啦！！！优质岗位等你来挑</title><link>https://mp.weixin.qq.com/s/uW8crplPtDvZdMhc7HpkAg</link><description></description><content:encoded><![CDATA[博际生物喊你入职啦！！！优质岗位等你来挑]]></content:encoded><pubDate>Fri, 23 Apr 2021 19:47:59 +0800</pubDate></item><item><title>肿瘤免疫治疗靶点及相关小分子抑制剂/激动剂</title><link>https://mp.weixin.qq.com/s/H4l7p-Aoxnz8hvmK9uyk8Q</link><description></description><content:encoded><![CDATA[肿瘤免疫治疗靶点及相关小分子抑制剂/激动剂]]></content:encoded><pubDate>Thu, 22 Apr 2021 19:53:45 +0800</pubDate></item><item><title>10-100万年薪，诚聘AI算法、肿瘤免疫、抗体药物科学家</title><link>https://mp.weixin.qq.com/s/MlPMNvEEjyhXubZ3WtlReA</link><description></description><content:encoded><![CDATA[10-100万年薪，诚聘AI算法、肿瘤免疫、抗体药物科学家]]></content:encoded><pubDate>Thu, 22 Apr 2021 19:53:45 +0800</pubDate></item><item><title>中美药品专利链接制度比较（附政策法规数据库）</title><link>https://mp.weixin.qq.com/s/6cIvjI52XTJ54qoTvtgixQ</link><description></description><content:encoded><![CDATA[中美药品专利链接制度比较（附政策法规数据库）]]></content:encoded><pubDate>Wed, 21 Apr 2021 19:47:59 +0800</pubDate></item><item><title>全球ADC药物研发概况</title><link>https://mp.weixin.qq.com/s/mCPJaquJ9xQPKPGnG4G6CA</link><description></description><content:encoded><![CDATA[全球ADC药物研发概况]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:44:20 +0800</pubDate></item><item><title>PD-1/PD-L1相关药物发明的专利保护</title><link>https://mp.weixin.qq.com/s/3j8gp83E4sgAdhx4pxStdw</link><description></description><content:encoded><![CDATA[PD-1/PD-L1相关药物发明的专利保护]]></content:encoded><pubDate>Mon, 19 Apr 2021 06:12:17 +0800</pubDate></item><item><title>Nature科普视频| 一款新型疫苗是如何诞生的</title><link>https://mp.weixin.qq.com/s/8dtkNTepl5Kw5IzOzLBbmw</link><description></description><content:encoded><![CDATA[Nature科普视频| 一款新型疫苗是如何诞生的]]></content:encoded><pubDate>Sun, 18 Apr 2021 06:28:51 +0800</pubDate></item><item><title>FDA撤销了单克隆抗体Bamlanivimab的紧急使用授权</title><link>https://mp.weixin.qq.com/s/c2bVAEaYGl8NRjSvxxag3A</link><description></description><content:encoded><![CDATA[FDA撤销了单克隆抗体Bamlanivimab的紧急使用授权]]></content:encoded><pubDate>Sat, 17 Apr 2021 09:43:12 +0800</pubDate></item><item><title>抗SARS-CoV-2中和抗体的临床进展</title><link>https://mp.weixin.qq.com/s/mZJ-o2FhjWDrx-FjZLbw-A</link><description></description><content:encoded><![CDATA[抗SARS-CoV-2中和抗体的临床进展]]></content:encoded><pubDate>Sat, 17 Apr 2021 09:43:12 +0800</pubDate></item><item><title>创新蓝海，百药争鸣｜BiG七周年半壁江山阵容揭秘</title><link>https://mp.weixin.qq.com/s/v0QOhOv8PFfA2tT5AuG3Ag</link><description></description><content:encoded><![CDATA[创新蓝海，百药争鸣｜BiG七周年半壁江山阵容揭秘]]></content:encoded><pubDate>Sat, 17 Apr 2021 09:43:12 +0800</pubDate></item><item><title>双特异性抗体：on-target off-tumor毒性及克服策略</title><link>https://mp.weixin.qq.com/s/34IIx64TuHCwMOuLTvlDFg</link><description></description><content:encoded><![CDATA[双特异性抗体：on-target off-tumor毒性及克服策略]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:28:33 +0800</pubDate></item><item><title>共创未来，博际生物招贤纳士</title><link>https://mp.weixin.qq.com/s/5-Sqh5OR_WGdt1ZyWnuqKQ</link><description></description><content:encoded><![CDATA[共创未来，博际生物招贤纳士]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:28:33 +0800</pubDate></item></channel></rss>